Piclidenoson not checked

Can-Fite BioPharma · CF101

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
3 active
11 in total · 2 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Piclidenoson is a selective A3AR agonist, supplied as tablets.”In the company’s words, NCT06643260 on ClinicalTrials.gov
Tested for
Plaque Psoriasis, Lowe Syndrome
Main trialPhase 3
“This is a double-blind, placebo-controlled study in adults with a diagnosis of moderate-to-severe chronic plaque psoriasis to test the efficacy and safety of piclidenoson in this patient population.”In the company’s words, NCT06643260 on ClinicalTrials.gov
Other names
CF101 · IB-MECA

Other drugs for Plaque Psoriasis

All 41 drugs for Plaque Psoriasis

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials11

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting Dec 2027 A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
Phase 2Not yet recruiting 31 Aug 2027 An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome
Phase 3Completed Nov 2013 Trial of CF101 to Treat Patients With Dry Eye Disease
Phase 3Completed 6 Jan 2022 CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
Phase 2Completed Apr 2007 Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
Phase 2Completed May 2009 Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Phase 2Completed Sep 2009 Safety and Efficacy Study of CF101 to Treat Psoriasis
Phase 2Completed Dec 2013 Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis
Phase 2Completed Dec 2016 Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Phase 2Completed 6 Mar 2022 Piclidenoson for Treatment of COVID-19
Phase 2Authorised not given An open-label, phase 2 pilot study on the efficacy and safety of Piclidenoson in patients with Lowe syndrome
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Piclidenoson

Following is part of Solo: you see every change to Piclidenoson the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in